STOCK TITAN

Hutchmed (China) Limited - HCM STOCK NEWS

Welcome to our dedicated page for Hutchmed (China) news (Ticker: HCM), a resource for investors and traders seeking the latest updates and insights on Hutchmed (China) stock.

HUTCHMED (China) Limited (NASDAQ:HCM) delivers innovative oncology and immunology therapies through cutting-edge research and global clinical development. This news hub provides investors with timely updates on regulatory milestones, clinical trial progress, and strategic partnerships shaping the future of targeted cancer treatments.

Access official press releases covering drug approvals, financial results, and scientific breakthroughs alongside analysis of market-moving developments. Our curated collection includes updates on key therapies like fruquintinib (Elunate®) and sovleplenib, with insights into their commercial expansion across global markets.

Discover critical updates across three core areas: Clinical Development (Phase I-III trial results), Regulatory Strategy (FDA/EMA/NMPA interactions), and Commercial Operations (partnerships with Takeda, AstraZeneca). Bookmark this page for verified information directly from company filings and authorized communications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
partnership
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.44%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags

FAQ

What is the current stock price of Hutchmed (China) (HCM)?

The current stock price of Hutchmed (China) (HCM) is $15.16 as of April 29, 2025.

What is the market cap of Hutchmed (China) (HCM)?

The market cap of Hutchmed (China) (HCM) is approximately 2.4B.
Hutchmed (China) Limited

Nasdaq:HCM

HCM Rankings

HCM Stock Data

2.37B
174.10M
0.13%
4.05%
0.22%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Hong Kong
CAMBRIDGE